LABCORP HOLDINGS INC.
Public company- Headquarters
- BURLINGTON, North Carolina
- Ticker
- LH
- CIK
- 0000920148
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| Feb 2, 2024 | 239 | 239 |
| May 13, 2024 | 81 | 320 |
| Sep 16, 2024 | 53 | 373 |
| Mar 3, 2025 | 73 | 446 |
| Mar 17, 2026 | 60 | 506 |
| Jul 3, 2026 | 83 | 589 |
Leadership
| Role and person | Since | Change |
|---|---|---|
| Executive Vice President and President, Central Laboratories and InternationalMegan D. Bailey | Aug 14, 2026 | Departed |
| Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific OfficerBrian J. Caveney, M.D. | Aug 14, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Fortrea Holdings Inc.
Chief Accounting Officer appointed: Carrie Russell
- Guardant Health, Inc.
Class II director appointed: Kevin R. Sayer
- QUEST DIAGNOSTICS INC
Executive Vice President role change: Catherine T. Doherty
- Celcuity Inc.
director appointed: David W. Gryska
- Executive departure
Executive Vice President and President, Central Laboratories and International departs: Megan D. Bailey
Megan D. Bailey, Executive Vice President and President, Central Laboratories and International of LABCORP HOLDINGS INC., resigns the role, effective September 4, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 14, 2026Role: Executive Vice President and President, Central Laboratories and International
- Executive appointment
Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer appointed: Brian J. Caveney, M.D.
Brian J. Caveney, M.D. was named Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer of LABCORP HOLDINGS INC., effective September 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 14, 2026Role: Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
- WARN notice
WARN notice: Raritan, NJ
Labcorp Raritan filed a WARN notice with the New Jersey WARN list covering 83 workers in Raritan. The layoffs take effect on Jul 3, 2026.
Source: New Jersey WARN list, filed Jul 3, 2026Site: Raritan, NJ
Workers affected: 83
- WARN notice
WARN notice: Southaven, MS
Laboratory Corporation of America filed a WARN notice with the Mississippi WARN list on Mar 17, 2026 covering 60 workers in Southaven.
Source: Mississippi WARN list, filed Mar 17, 2026Site: Southaven, MS
Workers affected: 60
layoffs from May 16, 2025
Plant closurePlant closure: CA
Laboratory Corporation of America Holdings filed a WARN notice with the California WARN list on Mar 3, 2025 covering 73 workers. The site closes on May 16, 2025.
Source: California WARN list, filed Mar 3, 2025Site: CA
Workers affected: 73
layoffs from Nov 22, 2024
WARN noticeWARN notice: Houston, TX
Laboratory Corporation of America Holdings filed a WARN notice with the Texas WARN list on Sep 16, 2024 covering 53 workers in Houston. The layoffs take effect on Nov 22, 2024.
Source: Texas WARN list, filed Sep 16, 2024Site: Houston, TX
Workers affected: 53
layoffs from Jul 19, 2024
Plant closurePlant closure: CA
Laboratory Corporation of America Holdings filed a WARN notice with the California WARN list on May 13, 2024 covering 81 workers. The site closes on Jul 19, 2024.
Source: California WARN list, filed May 13, 2024Site: CA
Workers affected: 81
- WARN notice
WARN notice: Somerset, NJ
Labcorp filed a WARN notice with the New Jersey WARN list covering 239 workers in Somerset. The layoffs take effect on Feb 2, 2024.
Source: New Jersey WARN list, filed Feb 2, 2024Site: Somerset, NJ
Workers affected: 239
Last verified Nov 8, 2026